HOME PEOPLE RESEARCH OPPORTUNITIES PUBLICATIONS COLLABORATORS LINKS ALUMNI CONTACT US
Recent Day Lab Publications

1. Davis JN. and Day M.L. The Convergence of Hormone Regulation and Cell Cycle in Prostate Physiology and Prostate Tumorigenesis. Molecular Biotechnology. 22(2):129-38. 2002.

2. Day, K.C., McCabe, M.T., Zhao, X., Wang, YZ., Davis, J.N., Phillips, J., Von Geldern, M., Ried, T., KuKuruga, M.A., Cunha, G.R., Hayward, S.W., and Day, M.L.: Homozygous Disruption of the Retinblastoma Gene Alters Cell Cycle and Growth Kinetics but does not Influence Prostatic Differentiation or Morphogenesis. Journal of Biological Chemistry. 2002. 277(46): 44475-44484.

3. Rios-Doria, J., Day, K.C., Kuefer, R., Rashid, M.G. and Day, M.L. Calpain-mediated Inactivation of E-cadherin in Prostate and Mammary Epithelial Cells. Journal of Biological Chemistry. 278(2):1372-9. 2003.

4. Kuefer R, Hofer MD, Gschwend JE, Pienta KJ, Sanda MG, Chinnaiyan AM, Rubin MA and Day ML. The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancer. Clin. Cancer Res. 9(17):6447-52. 2003.

5. Rios-Doria J, Kuefer R, Ethier SP, and Day ML. Cleavage and activation of b-catenin by calpain in prostate
and mammary tumor cells. Cancer Res. 2004 Oct 15;64(20):7237-40.

6. Rios-Doria J and Day ML. Truncated E-cadherin potentiates cell death in prostate epithelial cells.
The Prostate. 2005 May 15;63(3):259-68.

7. McCabe MT, Azih O. and Day ML. Rb-Independent Growth Arrest and Transcriptional Regulation of E2F
Target Genes. Neoplasia Feb;7(2):141-51. 2005.

8. Davis JN, McCabe MT Hayward, SW and Day ML. The Regulation of COX-2 Expression and
Function by E2F1 in Prostate Epithelium. Cancer Research May 1;65(9):3633-42. 2005.

9. McCabe MT, Davis JN, and Day ML. Regulation of the DNA Methylation and Gene Silencing
Through the pRb/E2F1 Pathway. Cancer Research May 1;65(9):3624-32. 2005.

10. Kuefer R., Zorn C., Hoefer M., Rubin M. and Day ML. Assessment of a fragment of E- cadherin as a serum biomarker with predictive value for prostate cancer. Br J Cancer. June 6;92(11):2018-23. 2005.

11. Hayward S, Wang YZ, Day M.L. Rescue and Isolation of Rb-deficient Prostate Epithelium
by Tissue Recombination. Cancer Cell Signaling, In Eds. David Terrian. Humana Press. 2002.

12. McCabe MT, J.A. Low, M.J. Imperiale, K.J. Wojno, and Day ML. Inhibition of DNA methyltransferase activity prevents tumor progression in a mouse model of prostate cancer. Cancer Research. 1;66(1):385-92. 2006.

13. McCabe MT, J.A. Low, M.J. Imperiale, and Day ML. Human Polyomavirus BKV Transcriptionally Activates DNA Methyltransferase 1 Through the pRb/E2F Pathway. In Press Oncogene.

14. 1. R. Kuefer, K. C. Day, C. G. Kleer, M. S. Sabel, M. D. Hofer, S. Varambally, C. S. Zorn, A. M. Chinnaiyan, M. A. Rubin and Mark L. Day. The ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease. Neoplasia. 2006. 8(4): 319-329.

 
Other Publications from Dr. Day's Curriculum Vitae